Institutions / Bb Biotech AG
Bb Biotech AG
CIK 924223 · Institution · as of Dec 31, 2014
Portfolio value
$3.09B
Positions
28
As of
Dec 31, 2014
Top holdings
Dec 31, 2014View all 28 →
| Company | Value | % of portfolio |
|---|---|---|
| Celgene Corp. | $415.48M | 13.5% |
| Isis Pharmaceuticals Inc. | $368.99M | 12.0% |
| Incyte CorpINCY | $296.23M | 9.6% |
| Gilead Sciences IncGILD | $277.65M | 9.0% |
| Agios Pharmaceuticals IncAGIO | $208.95M | 6.8% |
| Vertex Pharmaceuticals Inc / MaVRTX | $160.91M | 5.2% |
| Medivation Inc. | $137.93M | 4.5% |
| Alexion Pharmaceuticals Inc. | $124.42M | 4.0% |
| Radius Health Inc. | $107.09M | 3.5% |
| Synageva BioPharma Corp. | $104.90M | 3.4% |
| Puma Biotechnology, Inc.PBYI | $98.80M | 3.2% |
| Pharmacyclics Inc. | $89.44M | 2.9% |
| Regeneron Pharmaceuticals IncREGN | $81.23M | 2.6% |
| Receptos Inc. | $79.78M | 2.6% |
| Alnylam Pharmaceuticals, Inc.ALNY | $72.88M | 2.4% |
| Neurocrine Biosciences IncNBIX | $68.95M | 2.2% |
| Halozyme Therapeutics IncHALO | $65.87M | 2.1% |
| Ptc Therapeutics, Inc.PTCT | $63.57M | 2.1% |
| Tetraphase Pharmaceuticals Inc. | $51.71M | 1.7% |
| Novavax Inc. | $46.85M | 1.5% |
| Infinity Pharmaceuticals Inc.INFIQ | $39.20M | 1.3% |
| Clovis Oncology Inc. | $34.62M | 1.1% |
| Tesaro Inc. | $26.20M | 0.8% |
| ImmunoGen Inc. | $19.77M | 0.6% |
| Cempra Inc. | $18.22M | 0.6% |
Activity
Dec 31, 2014
InsidersInstitutions
This fund's quarter-over-quarter position changes — what it's buying and selling.No quarter-over-quarter changes yet. Position changes appear once we have two consecutive quarterly reports for this manager. We currently hold 1 quarter of holdings.